There was a difference in gender ratio between p53 positive and negative (P = 0.036); however, there was no difference in other clinicopathological factors such as preoperative tumour markers and lymph node metastasis (Table 1). This evidence concerns the gene TP53 and metastatic malignant neoplasm in the lymph nodes.